- Home
- ORMP vs GALT Comparison
ORMP vs GALT Comparison
Compare ORMP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- GALT
- Stock Information
- Founded
- ORMP 2002
- GALT 2000
- Country
- ORMP United States
- GALT United States
- Employees
- ORMP N/A
- GALT N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- GALT Health Care
- Exchange
- ORMP Nasdaq
- GALT Nasdaq
- Market Cap
- ORMP N/A
- GALT 83.5M
- IPO Year
- ORMP N/A
- GALT N/A
- Fundamental
- Price
- ORMP $2.16
- GALT $2.15
- Analyst Decision
- ORMP Hold
- GALT Buy
- Analyst Count
- ORMP 1
- GALT 2
- Target Price
- ORMP N/A
- GALT $6.00
- AVG Volume (30 Days)
- ORMP 77.2K
- GALT 1.4M
- Earning Date
- ORMP 08-15-2025
- GALT 08-12-2025
- Dividend Yield
- ORMP N/A
- GALT N/A
- EPS Growth
- ORMP N/A
- GALT N/A
- EPS
- ORMP N/A
- GALT N/A
- Revenue
- ORMP $2,000,000.00
- GALT N/A
- Revenue This Year
- ORMP N/A
- GALT N/A
- Revenue Next Year
- ORMP N/A
- GALT N/A
- P/E Ratio
- ORMP N/A
- GALT N/A
- Revenue Growth
- ORMP 196.74
- GALT N/A
- 52 Week Low
- ORMP $1.82
- GALT $0.73
- 52 Week High
- ORMP $3.09
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- ORMP 48.10
- GALT 55.44
- Support Level
- ORMP $2.10
- GALT $2.08
- Resistance Level
- ORMP $2.25
- GALT $2.66
- Average True Range (ATR)
- ORMP 0.08
- GALT 0.55
- MACD
- ORMP 0.00
- GALT -0.03
- Stochastic Oscillator
- ORMP 52.63
- GALT 30.56
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.